Navigation Links
Adolescent insomnia linked to depression and substance abuse during adolescence and young adulthood
Date:9/30/2008

Westchester, Ill. A study in the Oct. 1 issue of the journal Sleep shows that adolescent insomnia symptoms are associated with depression, suicide ideation and attempts, and the use of alcohol, cannabis and other drugs such as cocaine.

Findings suggest that the presence of insomnia in adolescents increases the risk of developing mental health problems and also may increase the severity of these problems. Results indicate that adolescents who had symptoms of insomnia were 2.3 times more likely to develop depression in early adulthood than adolescents without symptoms of insomnia. Specifically, at baseline, the insomnia group was more likely to use alcohol, cannabis, and non-cannabis drugs, and was more likely to suffer from depression, suicide thoughts, and suicide attempts. The insomnia group also had a greater risk of developing new incidences of depression and suicide attempts after excluding participants who suffered from these specific psychopathologies at baseline.

When excluding participants who endorsed any mental health problem at baseline, the insomnia group was significantly more likely to develop incident depression. In addition, gender differences emerged for alcohol use, cannabis use, non-cannabis drug use, and depression. Independently of insomnia status, males were significantly more likely to endorse alcohol use, cannabis use, and the use of other drugs, while females were twice as likely to develop depression.

"Previous research in adults has found similar results to this study," said principal investigator and lead author Brandy M. Roane, MS, a doctoral student at the University of North Texas. "The current study suggests adolescents with insomnia are more prone to developing mental disorders, specifically depression."

Insomnia symptoms were reported by 9.4 percent of the adolescents in the study. Information discovered during this study could potentially provide parents, educators and mentors with a sign of a risk factor for the development of mental health issues.

The study involved 4,494 adolescents between 12 and 18 years of age at the beginning of the study, and 3,582 young adults between the ages of 18 and 25 years in a six-to-seven year follow up. One-hundred and forty-five U.S. middle, junior and high schools were selected to participate based on size, school type, census region, level of urbanization, percentage of Caucasian and African-American students, grade span and curriculum. Health-related variables such as height, weight, pubertal development, mental health status, and chronic and disabling conditions were obtained through in-home interviews and self-report.

Adolescents who reported having trouble falling asleep every day or almost every day were categorized as having insomnia symptoms. Binge drinking was defined as drinking five or more alcoholic beverages in a row, and suicide ideation was based on whether or not a participant had endorsed having thoughts of suicide in the last year.


'/>"/>

Contact: Kelly Wagner
kwagner@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Related medicine news :

1. Global Health Project targets reducing AIDS among Indias adolescents
2. Study finds post-traumatic stress symptoms in adolescent children of cancer patients
3. Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents
4. Aggression in adolescents is influenced by siblings
5. American Academy of Child and Adolescent Psychiatry Reacts to S-CHIP Veto
6. New tool to assess excessive daytime sleepiness in adolescents published in JCSM
7. US FDA approves ABILIFY for adolescent patients with schizophrenia
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
9. Eating disorders in adolescents
10. Latin American adolescents are more likely to become infected with HIV than Spanish
11. New upper limit defined for normal ALT in adolescent males
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... Western University of ... services to the developmentally disabled in the Coachella Valley. , The two entities, ... facility at 71-949 Highway 111, Suite 100-B, in Rancho Mirage, California. The new ...
(Date:2/10/2016)... ... ... As part of its ongoing series of aquatic therapy related webinars, HydroWorx is ... expert and thoughtful presentation to give attendees a better sense of how to use ... to attend, but registration is required. , Rehabilitation of Offensive Lineman Utilizing ...
(Date:2/10/2016)... ... 2016 , ... Intermedix announced on Wednesday that it was ... medicine professional association, to support the organization's newly established physician group with a ... Medicine, or AAEM, seeks to empower emergency physicians to control their own practices. ...
(Date:2/10/2016)... Garland, TX (PRWEB) , ... February 10, 2016 ... ... the commencement of a master charity program created to assist the local community. ... closely with community leaders and nonprofit organizations in the area. Their goal is ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Exactus Pharmacy Solutions, a WellCare (NYSE: ... care for those suffering from long-term, life-threatening or ... Specialty Pharmacy Accreditation from URAC, an independent, nonprofit ... care quality through accreditation, education and measurement. ... URAC accreditation process demonstrates a commitment to quality ...
(Date:2/11/2016)...  Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare ... conditions, announced today that the Company will present its ... on Tuesday, February 16, 2016, at 4:30 p.m. ET.  ... overview of its business and growth strategy, as well ... 31, 2015. --> ...
(Date:2/11/2016)... -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) (the "Company"), ... a once-daily, oral therapy for the treatment of liver ... Maya Halpern , has notified the Company that she ... from its Board of Directors effective as of April ... Allen Baharaff . Mr. Baharaff continued, "While we ...
Breaking Medicine Technology: